{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T04:59:28Z","timestamp":1783486768387,"version":"3.55.0"},"reference-count":38,"publisher":"American Association for Cancer Research (AACR)","issue":"24","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2017,12,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Germline RB1 mutations strongly predispose humans to cone precursor\u2013derived retinoblastomas and strongly predispose mice to pituitary tumors, yet shared cell type\u2013specific circuitry that sensitizes these different cell types to the loss of RB1 has not been defined. Here we show that the cell type\u2013restricted thyroid hormone receptor isoform TR\u03b22 sensitizes to RB1 loss in both settings by antagonizing the widely expressed and tumor-suppressive TR\u03b21. TR\u03b22 promoted expression of the E3 ubiquitin ligase SKP2, a critical factor for RB1-mutant tumors, by enabling EMI1\/FBXO5\u2013dependent inhibition of SKP2 degradation. In RB1 wild-type neuroblastoma cells, endogenous Rb or ectopic TR\u03b22 was required to sustain SKP2 expression as well as cell viability and proliferation. These results suggest that in certain contexts, Rb loss enables TR\u03b21-dependent suppression of SKP2 as a safeguard against RB1-deficient tumorigenesis. TR\u03b22 counteracts TR\u03b21, thus disrupting this safeguard and promoting development of RB1-deficient malignancies. Cancer Res; 77(24); 6838\u201350. \u00a92017 AACR.<\/jats:p>","DOI":"10.1158\/0008-5472.can-16-3299","type":"journal-article","created":{"date-parts":[[2017,10,2]],"date-time":"2017-10-02T21:10:34Z","timestamp":1506978634000},"page":"6838-6850","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["SKP2 Activation by Thyroid Hormone Receptor \u03b22 Bypasses Rb-Dependent Proliferation in Rb-Deficient Cells"],"prefix":"10.1158","volume":"77","author":[{"given":"Xiaoliang L.","family":"Xu","sequence":"first","affiliation":[{"name":"1Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York."},{"name":"2Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York."},{"name":"3Sloan-Kettering Institute, Memorial Sloan-Kettering Cancer Center, New York, New York."},{"name":"4Zhongshan Ophthalmic Center, Zhongshan University, Guangzhou, P.R. China."},{"name":"5New York Eye and Ear Infirmary, New York Medical College, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengke","family":"Li","sequence":"additional","affiliation":[{"name":"6The Vision Center, Department of Surgery and The Saban Research Institute, Children's Hospital Los Angeles, Los Angeles, California."},{"name":"7Department of Cancer Genetics and Epigenetics, Beckman Research Institute, City of Hope, Duarte, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aihong","family":"Liu","sequence":"additional","affiliation":[{"name":"2Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianqun","family":"Fan","sequence":"additional","affiliation":[{"name":"8Department of Ophthalmology, Ninth People's Hospital, Shanghai Jiaotong University, Shanghai, P.R. China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan-ning","family":"Hu","sequence":"additional","affiliation":[{"name":"5New York Eye and Ear Infirmary, New York Medical College, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Lai","family":"Qi","sequence":"additional","affiliation":[{"name":"6The Vision Center, Department of Surgery and The Saban Research Institute, Children's Hospital Los Angeles, Los Angeles, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W.","family":"Chitty","sequence":"additional","affiliation":[{"name":"1Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renbing","family":"Jia","sequence":"additional","affiliation":[{"name":"1Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York."},{"name":"8Department of Ophthalmology, Ninth People's Hospital, Shanghai Jiaotong University, Shanghai, P.R. China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianping","family":"Qui","sequence":"additional","affiliation":[{"name":"1Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin Q.","family":"Wang","sequence":"additional","affiliation":[{"name":"1Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York."},{"name":"2Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jake","family":"Sharaf","sequence":"additional","affiliation":[{"name":"1Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zou","sequence":"additional","affiliation":[{"name":"1Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Weiss","sequence":"additional","affiliation":[{"name":"1Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyan","family":"Huang","sequence":"additional","affiliation":[{"name":"1Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter J.","family":"Joseph","sequence":"additional","affiliation":[{"name":"1Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lily","family":"Ng","sequence":"additional","affiliation":[{"name":"9National Institute of Diabetes and Digestive and Kidney Diseases, NIH, Bethesda, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Rosen","sequence":"additional","affiliation":[{"name":"5New York Eye and Ear Infirmary, New York Medical College, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binghui","family":"Shen","sequence":"additional","affiliation":[{"name":"7Department of Cancer Genetics and Epigenetics, Beckman Research Institute, City of Hope, Duarte, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark W.","family":"Reid","sequence":"additional","affiliation":[{"name":"6The Vision Center, Department of Surgery and The Saban Research Institute, Children's Hospital Los Angeles, Los Angeles, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas","family":"Forrest","sequence":"additional","affiliation":[{"name":"9National Institute of Diabetes and Digestive and Kidney Diseases, NIH, Bethesda, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David H.","family":"Abramson","sequence":"additional","affiliation":[{"name":"2Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Singer","sequence":"additional","affiliation":[{"name":"2Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Cobrinik","sequence":"additional","affiliation":[{"name":"6The Vision Center, Department of Surgery and The Saban Research Institute, Children's Hospital Los Angeles, Los Angeles, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suresh C.","family":"Jhanwar","sequence":"additional","affiliation":[{"name":"1Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York."},{"name":"11Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2017,12,14]]},"reference":[{"key":"2022061706163954600_bib1","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/nature10275","article-title":"A continuum model for tumour suppression","volume":"476","author":"Berger","year":"2011","journal-title":"Nature"},{"key":"2022061706163954600_bib2","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1073\/pnas.68.4.820","article-title":"Mutation and cancer: statistical study of retinoblastoma","volume":"68","author":"Knudson","year":"1971","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022061706163954600_bib3","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1242\/dmm.008060","article-title":"Newly identified aspects of tumor suppression by RB","volume":"4","author":"Viatour","year":"2011","journal-title":"Dis Models Mech"},{"key":"2022061706163954600_bib4","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0092-8674(95)90385-2","article-title":"The retinoblastoma protein and cell cycle control","volume":"81","author":"Weinberg","year":"1995","journal-title":"Cell"},{"key":"2022061706163954600_bib5","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nrc2399","article-title":"Cellular mechanisms of tumour suppression by the retinoblastoma gene","volume":"8","author":"Burkhart","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"2022061706163954600_bib6","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1002\/jcp.24329","article-title":"RB1 in cancer: different mechanisms of RB1 inactivation and alterations of pRb pathway in tumorigenesis","volume":"228","author":"Di Fiore","year":"2013","journal-title":"J Cell Physiol"},{"key":"2022061706163954600_bib7","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1200\/JCO.2005.05.054","article-title":"Risk of new cancers after radiotherapy in long-term survivors of retinoblastoma: an extended follow-up","volume":"23","author":"Kleinerman","year":"2005","journal-title":"J Clin Oncol"},{"key":"2022061706163954600_bib8","doi-asserted-by":"crossref","first-page":"3916","DOI":"10.1073\/pnas.96.7.3916","article-title":"RB-mediated suppression of spontaneous multiple neuroendocrine neoplasia and lung metastases in Rb+\/- mice","volume":"96","author":"Nikitin","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022061706163954600_bib9","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/nature13748","article-title":"Cancer: the origin of human retinoblastoma","volume":"514","author":"Bremner","year":"2014","journal-title":"Nature"},{"key":"2022061706163954600_bib10","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.cell.2009.03.051","article-title":"Retinoblastoma has properties of a cone precursor tumor and depends upon cone-specific MDM2 signaling","volume":"137","author":"Xu","year":"2009","journal-title":"Cell"},{"key":"2022061706163954600_bib11","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/nature13813","article-title":"Rb suppresses human cone-precursor-derived retinoblastoma tumours","volume":"514","author":"Xu","year":"2014","journal-title":"Nature"},{"key":"2022061706163954600_bib12","doi-asserted-by":"crossref","first-page":"3463","DOI":"10.1038\/ncomms4463","article-title":"Skp2 suppresses apoptosis in Rb1-deficient tumours by limiting E2F1 activity","volume":"5","author":"Lu","year":"2014","journal-title":"Nat Commun"},{"key":"2022061706163954600_bib13","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/ng.498","article-title":"Skp2 is required for survival of aberrantly proliferating Rb1-deficient cells and for tumorigenesis in Rb1+\/- mice","volume":"42","author":"Wang","year":"2010","journal-title":"Nat Genet"},{"key":"2022061706163954600_bib14","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/nature08815","article-title":"Skp2 targeting suppresses tumorigenesis by Arf-p53-independent cellular senescence","volume":"464","author":"Lin","year":"2010","journal-title":"Nature"},{"key":"2022061706163954600_bib15","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1093\/jnci\/82.4.310","article-title":"Increased expression of the retinoblastoma gene in human colorectal carcinomas relative to normal colonic mucosa","volume":"8","author":"Gope","year":"1990","journal-title":"J Natl Cancer Inst"},{"key":"2022061706163954600_bib16","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/nature07310","article-title":"E2F1 represses beta-catenin transcription and is antagonized by both pRB and CDK8","volume":"455","author":"Morris","year":"2008","journal-title":"Nature"},{"key":"2022061706163954600_bib17","doi-asserted-by":"crossref","first-page":"e1004357","DOI":"10.1371\/journal.pgen.1004357","article-title":"Hyperactivated Wnt signaling induces synthetic lethal interaction with Rb inactivation by elevating TORC1 activities","volume":"10","author":"Zhang","year":"2014","journal-title":"PLoS Genet"},{"key":"2022061706163954600_bib18","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1210\/me.2007-0037","article-title":"An intron control region differentially regulates expression of thyroid hormone receptor beta2 in the cochlea, pituitary, and cone photoreceptors","volume":"21","author":"Jones","year":"2007","journal-title":"Mol Endocrinol"},{"key":"2022061706163954600_bib19","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1126\/science.1106642","article-title":"Proliferation of functional hair cells in vivo in the absence of the retinoblastoma protein","volume":"307","author":"Sage","year":"2005","journal-title":"Science"},{"key":"2022061706163954600_bib20","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.tem.2009.03.011","article-title":"Thyroid receptor: roles in cancer","volume":"20","author":"Aranda","year":"2009","journal-title":"Trends Endocrinol Metab"},{"key":"2022061706163954600_bib21","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1038\/onc.2010.464","article-title":"Thyroid hormone receptor beta1 domains responsible for the antagonism with the ras oncogene: role of corepressors","volume":"30","author":"Garcia-Silva","year":"2011","journal-title":"Oncogene"},{"key":"2022061706163954600_bib22","doi-asserted-by":"crossref","first-page":"5528","DOI":"10.1210\/en.2010-0475","article-title":"Tumor suppressor action of liganded thyroid hormone receptor beta by direct repression of beta-catenin gene expression","volume":"151","author":"Guigon","year":"2010","journal-title":"Endocrinology"},{"key":"2022061706163954600_bib23","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1158\/2159-8290.CD-15-1481","article-title":"Integrin-alpha10 Dependency identifies RAC and RICTOR as therapeutic targets in high-grade myxofibrosarcoma","volume":"10","author":"Okada","year":"2016","journal-title":"Cancer Discov"},{"key":"2022061706163954600_bib24","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/ng0796-354","article-title":"Thyroid hormone receptor beta is essential for development of auditory function","volume":"13","author":"Forrest","year":"1996","journal-title":"Nat Genet"},{"key":"2022061706163954600_bib25","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/83829","article-title":"A thyroid hormone receptor that is required for the development of green cone photoreceptors","volume":"27","author":"Ng","year":"2001","journal-title":"Nat Genet"},{"key":"2022061706163954600_bib26","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/12013","article-title":"SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27","volume":"1","author":"Carrano","year":"1999","journal-title":"Nat Cell Biol"},{"key":"2022061706163954600_bib27","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/nature02330","article-title":"Control of the SCF(Skp2-Cks1) ubiquitin ligase by the APC\/C(Cdh1) ubiquitin ligase","volume":"428","author":"Bashir","year":"2004","journal-title":"Nature"},{"key":"2022061706163954600_bib28","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/nature02381","article-title":"Degradation of the SCF component Skp2 in cell-cycle phase G1 by the anaphase-promoting complex","volume":"428","author":"Wei","year":"2004","journal-title":"Nature"},{"key":"2022061706163954600_bib29","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/ncb785","article-title":"E2F-dependent accumulation of hEmi1 regulates S phase entry by inhibiting APC(Cdh1)","volume":"4","author":"Hsu","year":"2002","journal-title":"Nat Cell Biol"},{"key":"2022061706163954600_bib30","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1128\/MCB.01830-06","article-title":"Cdh1-anaphase-promoting complex targets Skp2 for destruction in transforming growth factor beta-induced growth inhibition","volume":"27","author":"Liu","year":"2007","journal-title":"Mol Cell Biol"},{"key":"2022061706163954600_bib31","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0304-3835(02)00614-6","article-title":"Thyroid hormone receptors\/THR genes in human cancer","volume":"192","author":"Gonzalez-Sancho","year":"2003","journal-title":"Cancer Lett"},{"key":"2022061706163954600_bib32","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1158\/0008-5472.CAN-08-2198","article-title":"Thyroid hormone receptor beta1 acts as a potent suppressor of tumor invasiveness and metastasis","volume":"69","author":"Martinez-Iglesias","year":"2009","journal-title":"Cancer Res"},{"key":"2022061706163954600_bib33","doi-asserted-by":"crossref","first-page":"5019","DOI":"10.1038\/onc.2011.654","article-title":"Established and new mouse models reveal E2f1 and Cdk2 dependency of retinoblastoma, and expose effective strategies to block tumor initiation","volume":"31","author":"Sangwan","year":"2012","journal-title":"Oncogene"},{"key":"2022061706163954600_bib34","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1101\/gad.1196704","article-title":"Repression of the Arf tumor suppressor by E2F3 is required for normal cell cycle kinetics","volume":"18","author":"Aslanian","year":"2004","journal-title":"Genes Dev"},{"key":"2022061706163954600_bib35","first-page":"282","article-title":"Loss of heterozygosity in a gene coding for a thyroid hormone receptor in lung cancers","volume":"44","author":"Leduc","year":"1989","journal-title":"Am J Hum Genet"},{"key":"2022061706163954600_bib36","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1158\/1078-0432.CCR-11-3077","article-title":"Characterization of gene amplification-driven SKP2 overexpression in myxofibrosarcoma: potential implications in tumor progression and therapeutics","volume":"18","author":"Li","year":"2012","journal-title":"Clin Cancer Res"},{"key":"2022061706163954600_bib37","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0002-9440(10)64172-7","article-title":"A novel target gene, SKP2, within the 5p13 amplicon that is frequently detected in small cell lung cancers","volume":"161","author":"Yokoi","year":"2002","journal-title":"Am J Pathol"},{"key":"2022061706163954600_bib38","doi-asserted-by":"crossref","first-page":"6933","DOI":"10.1073\/pnas.94.13.6933","article-title":"Loss of the retinoblastoma protein-related p130 protein in small cell lung carcinoma","volume":"94","author":"Helin","year":"1997","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/77\/24\/6838\/2760801\/6838.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/77\/24\/6838\/2760801\/6838.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T13:56:52Z","timestamp":1655474212000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/77\/24\/6838\/624325\/SKP2-Activation-by-Thyroid-Hormone-Receptor-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,14]]},"references-count":38,"journal-issue":{"issue":"24","published-online":{"date-parts":[[2017,12,14]]},"published-print":{"date-parts":[[2017,12,15]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-16-3299","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.22416752","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22416752.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22416755.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6509639","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6509639.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22416755","asserted-by":"object"}],"has-review":[{"id-type":"doi","id":"10.3410\/f.731685371.793538204","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,14]]}}}